Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1603 of 6351
-
New shot aims to ease neck pain for months longer
Symptom relief Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of the study drug, Corabotase (also known as IPN10200), and to assess how well it works when compared with placebo in treating Cervical Dystonia (CD) in adults. CD can cause a series of abnormalities and symptoms i…
Phase 2 • Sponsor: Ipsen • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Could HIV drugs slow Alzheimer's? new safety trial begins
Disease control OngoingRecent studies have identified an association between Alzheimer's Disease (AD) and an expansion of DNA content in the brain (prefrontal cortex). This additional DNA content appears to be derived from reverse transcriptase (RT) activity that incorporates genomic cDNAs (gencDNAs) i…
Phase 1 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
CPAP-Free sleep solutions: mouth device vs. nerve implant showdown
Disease control Recruiting nowOSANOVA is a non-randomized clinical trial which aims to compare outcomes of mandibular advancement device (MAD) and hypoglossal nerve stimulation (HGNS) therapies in moderate-to-severe OSA patients who fail, decline, or are intolerant to positive airway pressure (PAP) therapy (r…
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New obesity drug GV101 shows promise in Mid-Stage trial
Disease control CompletedThe purpose of this trial is to evaluate the efficacy and safety of GV101 for weight loss over a range of doses in participants with obesity. The primary efficacy endpoint is the mean percent change in body weight from baseline at Week 16 in each treated group as compared with pl…
Phase 2 • Sponsor: Graviton Bioscience Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New rapid test could slash ER wait times for chest pain patients
Diagnosis Recruiting nowThe goal of this study is to evaluate whether a POC-guided testing strategy to exclude non-ST elevation myocardial infarction (NSTEMI) in acute chest pain patients presenting at the emergency department (ED) can result in a shorter length of stay compared to the routine central l…
Sponsor: KU Leuven • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
New hope for rare lung infection: weekly drug shows promise in early trial
Disease control OngoingThe goal of this clinical trial is to to evaluate the drug rezafungin in the treatment of Chronic Pulmonary Aspergillosis (CPA) in male and female patients aged 18 years and over with limited treatment options. The study aims to answer whether 6 months of rezafungin treatment is…
Phase 2 • Sponsor: Mundipharma Research Limited • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Neck ultrasound could keep heart failure patients out of the hospital
Disease control Recruiting nowHeart failure occurs when the heart cannot pump blood effectively, leading to fluid buildup in the body. This can cause problems such as difficulty breathing, swelling, and extreme tiredness. In severe cases, these symptoms worsen to the point where hospitalization is required. U…
Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Engineered immune cells take on liver cancer in early trial
Disease control Recruiting nowThis study is a single-centre, single-arm, open-label, dose-escalation exploratory study with single-dose administration. Its objective is to evaluate the safety, tolerability, dose, anti-tumor efficacy, and pharmacokinetic characteristics of CG-102-12C in the participants with G…
Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Your tooth, reborn: could a dentin graft outperform bone grafts?
Disease control CompletedTotal of 40 participants were planned for enrollment for socket preservation, 20 in the Autogenous Demineralized Dentin group and 20 in the Xenograft group these materials used for socket preservation after extraction. Participants were assessed for changes in bucco-lingual width…
Sponsor: Delta University for Science and Technology • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New study aims to calm inflammation in preterm infants
Disease control Recruiting nowA phase 2 randomised, three-arm, parallel-group, dose-ranging trial to determine safety, efficacy and optimal dosing of intravenous anakinra in premature neonates, with subcutaneous pharmacokinetic sub-study.
Phase 2 • Sponsor: Monash Medical Centre • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could restarting chemo after liver surgery keep cancer away?
Disease control Recruiting nowEligible patients are patients with contraindication to preoperative oxaliplatin based-chemotherapy who underwent resection of no more than 10 colorectal liver metastases after preoperative FOLFIRI based chemotherapy with or without targeted agents. These patients must have objec…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
New radiation technique aims to cut prostate cancer treatment side effects
Symptom relief OngoingThis clinical trial studies the side effects of computed tomography (CT)-guided stereotactic body radiation therapy (SBRT) with intrafraction motion monitoring and to see how well it works in treating patients with prostate cancer that has not spread to other parts of the body (l…
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
New pill aims to quiet Schizophrenia's worst symptoms
Symptom relief CompletedML-007C-MA-211 is a Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of orally administered ML-007C-MA in inpatient adult participants aged 18 to 64 years with schizophrenia experiencing an acute exacerbation of psycho…
Phase 2 • Sponsor: MapLight Therapeutics • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Can an app or zoom class lift depression in young breast cancer survivors?
Symptom relief Recruiting nowNRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs Ap…
Phase 3 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Could a headcap at home beat the blues? new trial tests brain zaps for depression
Symptom relief Recruiting nowThe REACH-tDCS study will evaluate the safety and efficacy of a noninvasive, at-home self-administered Sooma tDCS brain stimulation treatment for Major Depressive Disorder. The study uses randomized, blinded, placebo controlled design. The participants are assessed with video int…
Sponsor: Sooma Medical Inc • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
New drug aims to repair heart in common form of heart failure
Disease control Recruiting nowThis study will look into how CDR132L (a potential new medicine) works on the structure and function of the heart in people living with heart failure. Participants will either get CDR132L or placebo (a medicine which has no effect on the body), which treatment the participants ge…
Phase 2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New COPD pill aims to cut dangerous lung attacks
Disease control Recruiting nowThis Phase IIb dose-ranging study will evaluate the efficacy and safety of 2 different doses of AZD6793 compared with placebo tablets in participants with moderate to very severe chronic obstructive pulmonary disease.
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
New inhaled drug aims to stop lung infections in vulnerable blood cancer patients
Disease control Recruiting nowThe purpose of this research study is to try to see whether an experimental drug, PUL 042 Inhalation Solution (PUL 042), is effective in reducing the severity of lung infections in patients with hematologic malignancies and recipients of hematopoietic stem cell transplantation wi…
Phase 2 • Sponsor: Pulmotect, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Seaweed spray could soothe radiation mouth pain
Symptom relief OngoingTo evaluate the efficacy and safety of Spirulina-Derived Product for prevention and treatment of oral mucositis in patients undergoing radiotherapy for malignant head and neck tumors.
Phase 2 • Sponsor: West China Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New rapid blood test could cut hospital referrals for chest pain
Diagnosis OngoingAcute chest pain is a prevalent medical emergency in primary emergency care settings. Triage of chest pain prior to hospital admission presents significant challenges due to the absence of sufficiently sensitive diagnostic tools. Clinical signs, symptoms, risk assessment scores, …
Sponsor: University of Oslo • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC